![Lindsay Rosenwald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 15 M $ al 31/05/2026
Dr. Lindsay A. Rosenwald, MD, is an Executive Chairman at Cyprium Therapeutics, Inc., an Executive Chairman at Helocyte, Inc., an Executive Chairman at Journey Medical Corp., a Chairman, President & Chief Executive Officer at Fortress Biotech, Inc. and an Executive Chairman at Cellvation, Inc. He is on the Board of Directors at Mustang Bio, Inc., Avenue Therapeutics, Inc., Baergic Bio, Inc. and Caelum Biosciences, Inc. Dr. Rosenwald was previously employed as a Non-Executive Director by Checkpoint Therapeutics, Inc., a Co-Chairman & Chief Executive Officer by CB Pharma Acquisition Corp., a Co-Founder by TG Therapeutics, Inc., a Partner by Opus Point Partners Management LLC (Investment Management), a Chairman by Paramount Acquisition Corp., a Chairman & Chief Executive Officer by Paramount BioCapital, Inc., a Founder, Chairman & Chief Executive Officer by Paramount BioCapital Asset Management, Inc., a Founder, Chairman & Chief Executive Officer by Paramount BioSciences LLC, a Managing Director by Harris & Parks, Inc., and a Securities Analyst by Ladenburg Thalmann & Co., Inc. He also served on the board at Cougar Biotechnology, Inc. /Old/ and Keryx Biopharmaceuticals, Inc. He received his undergraduate degree from The Pennsylvania State University and a doctorate degree from Temple University School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
FORTRESS BIOTECH, INC. 13,81 % | 16/04/2026 | 4.586.841 ( 13,81 % ) | 13 M $ | 31/05/2026 |
| 05/08/2025 | 387.616 ( 1,8 % ) | 2 M $ | 31/05/2026 | |
| 25/11/2025 | 4.820 ( 0,15 % ) | 1 446 $ | 31/05/2026 | |
MUSTANG BIO, INC. 0,01 % | 18/11/2025 | 342 ( 0,01 % ) | 229 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| FORTRESS BIOTECH, INC. | Director Ejecutivo | 20/12/2013 |
| AVENUE THERAPEUTICS, INC. | Director/Miembro de la Junta | 07/03/2023 |
| MUSTANG BIO, INC. | Director/Miembro de la Junta | 13/03/2015 |
| JOURNEY MEDICAL CORPORATION | Presidente | 01/10/2014 |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of menkes disease and related copper metabolism disorders | Fundador | 01/01/2017 |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Director/Miembro de la Junta | - |
Helocyte, Inc.
 Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Fundador | 01/01/2015 |
Cellvation, Inc.
 Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Presidente | - |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 23 |
|---|---|
Paramount BioCapital Asset Management, Inc.
 Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Paramount BioCapital Asset Management manages hedge funds and private equity funds that focus on investments in healthcare and life sciences companies. The firm invests globally, with emphasis on the stocks of small-cap healthcare technology companies. | Finance |
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Alternative investment manager | Finance |
Paramount Acquisition Corp.
 Paramount Acquisition Corp. Financial ConglomeratesFinance Investment vehicle acquiring operating businesses in the healthcare industry | Finance |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ladenburg Thalmann & Co., Inc.
 Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Finance |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount invests in companies located in the United States. The firm focuses on companies operating in the fields of biotechnology, pharmaceutical development, healthcare and life-sciences sectors. | Finance |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance OPPM invests in and assists biotechnology and healthcare companies in developing and commercializing novel medicines and diagnostic tools. | Finance |
D.H. Blair & Co., Inc. | |
Temple University School of Medicine
 Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origo Acquisition Corp.
 Origo Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Checkpoint Therapeutics, Inc.
 Checkpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Avenue Therapeutics, Inc.
 Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Helocyte, Inc.
Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Health Technology |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
Cyprium Therapeutics, Inc.
Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of menkes disease and related copper metabolism disorders | Health Technology |
Cellvation, Inc.
Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Health Technology |
Journey Medical Corp.
 Journey Medical Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for the treatment of dermatological treatment conditions | Health Technology |
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Health Technology |
Baergic Bio, Inc.
Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
